Omeprazole Arrow

Omeprazole, the active ingredient in Omeprazole Arrow, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is employed in the management of acid‑related gastrointestinal conditions such as gastroesophageal reflux disease, peptic ulcer disease, and erosive esophagitis. The drug works by irreversibly blocking the final step of acid secretion in the stomach's parietal cells, providing prolonged symptom relief.

GNH USA supplies Omeprazole Arrow as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole Arrow is indicated for several acid‑related gastrointestinal disorders, acting to suppress gastric acid secretion.

- Gastroesophageal reflux disease (GERD): alleviates heartburn and regurgitation, promotes healing of inflamed esophageal tissue. - Peptic ulcer disease: facilitates ulcer healing by reducing gastric acidity and preventing recurrence. - Erosive esophagitis: diminishes acid exposure, allowing restoration of damaged esophageal lining. - Helicobacter pylori eradication regimens: used in combination therapy to improve eradication rates by suppressing acid.

Omeprazole may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild, transient headache reported by some patients. - Diarrhea: loose stools occurring during treatment. - Nausea: feeling of sickness or upset stomach. - Abdominal pain: discomfort or cramps in the stomach area.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis that can develop with prolonged use. - Severe allergic reaction: rash, swelling, or anaphylaxis requiring immediate medical attention. - Low magnesium levels: hypomagnesemia that may cause muscle cramps, irregular heartbeat, or seizures.

Before initiating Omeprazole Arrow, healthcare professionals should consider several precautionary measures to ensure safe use. - Assess renal function: adjust therapy in patients with severe renal impairment. - Monitor for infection: prolonged therapy may increase risk of Clostridioides difficile colitis. - Review concomitant medications: avoid use with drugs that require acidic environment for absorption. - Evaluate pregnancy status: discuss potential risks and benefits with the prescriber. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Omeprazole can affect the plasma concentrations of several co‑administered medicines, necessitating careful management.

Major Interactions (Avoid): - Clopidogrel: omeprazole reduces its antiplatelet effectiveness, increasing cardiovascular risk. - Atazanavir: gastric pH elevation markedly decreases atazanavir absorption, compromising HIV therapy. - Methotrexate: reduced clearance may lead to toxic accumulation, especially at high doses.

Moderate Interactions (Monitor Closely): - Warfarin: enhanced anticoagulant effect may raise INR; monitor coagulation parameters. - Digoxin: increased serum levels possible; observe for signs of toxicity.